Connect
Customer Care 0508 634 103(New Zealand) +64 9 259 4062(Overseas)

Revolutionary new CGM system eliminates routine fingerpricks* for people with diabetes and is nearly one-third slimmer than previous generation

10 March 2020

NZMS Diabetes is excited to announce the powerful and revolutionary Dexcom G6 Continuous Glucose Monitoring System (CGM) will be available in New Zealand for people with diabetes ages 2 years and up beginning in late April 2020.
“The Dexcom G6 represents the future of diabetes management. Not only does the product eliminate the need for fingerpricks, but it provides real time glucose data that empowers people with diabetes to better control their condition and live healthier lives,” said Paul Flynn, general manager for Americas and Asia Pacific at Dexcom.

New with Dexcom G6:

  • Fingerprick Elimination – No fingerpricks are needed for calibration or diabetes treatment decisions.*
  • Easy Sensor Applicator – Complete redesign of the sensor applicator allows for one-touch, simple insertion.
  • Predictive Low Alert – New alert feature predicts hypoglycaemia before it hits to help avoid dangerous low blood sugar events.
  • Extended 10-Day Sensor – 10-day sensor allows for 43% longer wear than previous generation Dexcom CGMs.
  • Discreet and Low Profile – A redesigned transmitter with a 28% lower profile than previous generation Dexcom CGMs makes the device comfortable and easy to wear under clothing.
  • Paracetamol Blocking – New feature that enables Paracetamol use without any effect on glucose readings. †

Dexcom G6 carries forward important features of current Dexcom CGM systems:

  • Continuous Glucose Readings – Automatically sends glucose readings to a Dexcom receiver or compatible smart device every five minutes.
  • Mobile App and Sharing – Compatibility with smart device apps allows for sharing glucose information with up to five people for added support. ǂ
  • Customisable Alarms and Alerts – Personalised alert schedule immediately warns the wearer of pending dangerous high and low blood sugars.

More details, including pricing options and exact availability dates, will be released by NZMS Diabetes in the coming weeks.

 

 

*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. ǂG6 readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000mg every six hours. Taking a higher dose may affect the G6 readings. †To view a list of compatible devices, visit www.dexcom.com/compatibility

Stay informed with NZMS

Now you can get all the latest news and updates of our products, events and resources right into your inbox.